References
- 1. Arslan S., Ugurlu S, Bulut G. Akkurt I. The association between plasma D-dimmer levels and community-acquired pneumonia. Clinics 2010; 65(6): 593–7.10.1590/S1807-59322010000600006289855020613935
- 2. Milbrandt EB, Reade MC, Lee M, et al. Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia. Molec Med 2009; 15(11–12): 438–445.10.2119/molmed.2009.00091274320519753144
- 3. Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia Chest, 2004; 126(4): 1087–1092.
- 4. Freyburger G, Trillaund H, Labrouche S, Gauther P, Javorschi S, Bernard P, et al D dimmer strategy in thrombosis exclusion- a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD metods compared. Thromb Haemost 1998; 79: 32–7.10.1055/s-0037-1614214
- 5. Levi M, Keller TT, Van Gorp E, Ten Cate H. Infection and inflammation and the coagulation system Cardiovasc. Res. 60(2003) 26–39.
- 6. Yende S, D’Angelo G, Mayr F, et al. Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths. Bozza PT, ed. PLoS ONE. 2011; 6(8): e22847.10.1371/journal.pone.0022847315426021853050
- 7. Light RW Parapneumonic effusions and empyema Proc Am Thorac Soc. 2006; 3(1): 75–80.10.1513/pats.200510-113JH16493154
- 8. Chapman SJ, Davies RJO The management of pleural space infection. Respitology 2004; 9: 4–11.
- 9. Light RW. Pleural diseases, 4th ed Baltimore: Lippincott, Williams and Wilkins; 2001.
- 10. Medford AR, Maskell N. Pleural effusion. Postgrad Med J 2005; 81: 702e10.10.1136/pgmj.2005.035352174339716272233
- 11. Costa Vaz MA, Vargas FS, Marinho FCA, D’Amico EA, Rocha TRF, Teixeira LR. Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions?. Clinics. 2009; 64(9): 891–5.10.1590/S1807-59322009000900010
- 12. Kabrhel C, Courtney DM, Camargo CA, et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Academic emergency medicine: 2010; 17(6): 589–597.10.1111/j.1553-2712.2010.00765.x353803120624138
- 13. Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. Journal of Inflammation. 2010; 7: 6.10.1186/1476-9255-7-6283700020181046
- 14. Barthwal M.S. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status. Indian journal of chest diseases and allied sciences 50.3 (2008): 277.
- 15. Satoshi G, Toshiaki I., Yutaka I, et al A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria Critical Care Medicine: 2006; 34(3): 625–631.
- 16. Kale S, Yende S, Kong L, et all The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS One. 2010; 5(11): e 13852.10.1371/journal.pone.0013852297397621085465
- 17. Lee MH, Nahm CH, Choi JW. Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflamemation in pleural effusions. Ann Clin Lab Sci. 2010 Fall; 40(4): 342–7.
- 18. Chalmers JD, Singanayagam A, Murray MP, et all. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009 Jul; 64(7): 592–7.10.1136/thx.2008.10508019131449
- 19. El-Habashy M, Elmahalawy I.I, Sonobol A. Value of D-dimer and alkaline phosphatase in the diagnosis of pleural effusion Egyptian Journal of Chest diseases and tuberculosis 2014; 63: 869–872.
- 20. Dikensoy O., Stathopoulos G.T., Zhu Z, Light R.W. D-dimmer levels in leural effusion Respiratory Medicine 2006; 100: 1337–1341.
- 21. Seligman R, Ramos-Lima LF, do Amaral Oliveira V, Sanvicente C, Pacheco EF, Rosa KD. Biomarkers in community-acquired pneumonia: A state-of-the-art review. Clinics. 2012; 67(11): 1321–1325.10.6061/clinics/2012(11)17
- 22. Christ-Crain M, Opal SM Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010; 14(1): 203.10.1186/cc8155
- 23. Rohacek M, Szucs-Farkas Z., Pfortmüller C.A. et all Acute Cardiac Disorder or Pneumonia and Concomitant Presence of Pulmonary Embolism. PLoS One. 2012; 7(10): e7418.10.1371/journal.pone.0047418
- 24. Woodhouse PR, Khnaw K T, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovasucalre disease. Lancet; 1994:19; 343: 435–439.10.1016/S0140-6736(94)92689-1
- 25. Serhan CN, Chiang N, Van Duke TE Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immnol 2008; 8: 349–361.10.1038/nri2294274459318437155
- 26. Kasal J, Jovanovic Z, Clermont G, Weissfeld LA, Kaplan V, et al. Comparison of Cox and Gray’s survival models in severe sepsis. Crit Care Med; 2004: 32: 700–707.10.1097/01.CCM.0000114819.37569.4B